Michael White, MD
Interventional Cardiology · Phoenix, AZNPI 1851481568
Payments from drug & device makers
What this record shows
9 manufacturers reported payments, led by Pfizer at 52.3% of the total. Reporting peaked in 2020 at $601 and has fallen 56.6% since, to $261 in 2025. That places this record below the midpoint for interventional cardiology clinicians in AZ, where the typical reported total is $10,657.
Across 12 payments — averaging $81.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$513
- Alphatec Spine, Inc$194
- Abiomed$124
- Terumo Medical Corporation$34
- Actelion Pharmaceuticals US, Inc.$32
- Philips North America LLC$26
- plus $57 from 3 others
Across 19 payments — averaging $21,880 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Hoffmann-la Roche Limited$351K
- Genentech, Inc.$60K
- Pfizer$4K
- AstraZeneca$436
What the payments were for
- Speaking & faculty fees$50051%
- Food & beverage$48149%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 2 | $513 |
| Alphatec Spine, Inc | 1 | $194 |
| Abiomed | 3 | $124 |
| Terumo Medical Corporation | 1 | $34 |
| Actelion Pharmaceuticals US, Inc. | 1 | $32 |
| Philips North America LLC | 1 | $26 |
| Johnson & Johnson | 1 | $19 |
| Daiichi Sankyo Inc. | 1 | $19 |
| Boston Scientific | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LIF$194
- Other - Miscellaneous$194
- INVICTUS OPEN$194
How this compares
$981 in reported general payments places this provider in the 10th percentile of 223 interventional cardiology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Phoenix
- Paul SorajjaPhoenix$1.1M
- Timothy ByrnePhoenix$614K
- Haidar YassinPhoenix$434K
- Akil LoliPhoenix$160K
- Nishant GuptaPhoenix$145K
- Richard HeuserPhoenix$68K
- Nezar FallujiPhoenix$50K
- Ahmad JabriPhoenix$39K
- Edward EvansPhoenix$36K
- Basil Al KhatibPhoenix$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.